Andrew R Belch: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial

Weisel, Katja, Dimopoulos, Meletios, Song, Kevin W., Moreau, Philippe, Palumbo, Antonio, Belch, Andrew, Schey, Stephen, Sonneveld, Pieter, Sternas, Lars, Yu, Xin, Amatya, Ramesh, Gibson, Craig J., Zak

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2015

Language:

english

File:

PDF, 1.40 MB

english, 2015

2

Final analysis of survival outcomes in the randomized phase 3 FIRST trial

Facon, Thierry, Dimopoulos, Meletios A., Dispenzieri, Angela, Catalano, John V., Belch, Andrew, Cavo, Michele, Pinto, Antonello, Weisel, Katja, Ludwig, Heinz, Bahlis, Nizar J., Banos, Anne, Tiab, Mour

Journal:

Year:

2017

Language:

english

File:

PDF, 701 KB

english, 2017

3

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma : A randomized, double-blind, multicenter, comparative trial

Lee S. Rosen, David Gordon, Mary Kaminski, Anthony Howell, Andrew Belch, John Mackey, Justus Apffelstaedt, Mohamad A. Hussein, Robert E. Coleman, Dirk J. Reitsma, Bee-Lian Chen, John J. Seaman

Journal:

Year:

2003

Language:

english

File:

PDF, 151 KB

english, 2003

4

Microfluidic Chips for Detecting the t(4;14) Translocation and Monitoring Disease during Treatment Using Reverse Transcriptase-Polymerase Chain Reaction Analysis of IgH-MMSET Hybrid Transcripts

VanDijken, Jaron, Kaigala, Govind V., Lauzon, Jana, Atrazhev, Alexey, Adamia, Sophia, Taylor, Brian J., Reiman, Tony, Belch, Andrew R., Backhouse, Christopher J., Pilarski, Linda M.

Journal:

The Journal of Molecular Diagnostics

Year:

2007

Language:

english

File:

PDF, 743 KB

english, 2007

5

Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma

Toumishey, Ethan, Prasad, Angeli, Dueck, Greg, Chua, Neil, Finch, Daygen, Johnston, James, van der Jagt, Richard, Stewart, Doug, White, Darrell, Belch, Andrew, Reiman, Tony

Journal:

Year:

2015

Language:

english

File:

PDF, 165 KB

english, 2015

6

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

Lonial, Sagar, Weiss, Brendan M, Usmani, Saad Z, Singhal, Seema, Chari, Ajai, Bahlis, Nizar J, Belch, Andrew, Krishnan, Amrita, Vescio, Robert A, Mateos, Maria Victoria, Mazumder, Amitabha, Orlowski,

Journal:

Year:

2016

Language:

english

File:

PDF, 507 KB

english, 2016

7

Addressing heterogeneity of individual blood cancers: the need for single cell analysis

Chu, Michael P., Kriangkum, Jitra, Venner, Christopher P., Sandhu, Irwindeep, Hewitt, Joanne, Belch, Andrew R., Pilarski, Linda M.

Journal:

Cell Biology and Toxicology

Year:

2017

Language:

english

File:

PDF, 1.05 MB

english, 2017

8

Daratumumab, Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM Based on Prior Lines and Treatment Exposure: POLLUX

Dimopoulos, Meletios, Belch, Andrew R., White, Darrell J., Benboubker, Lofti, Cook, Gordon, Leiba, Merav, Morton, James, Ho, P. Joy, Kim, Kihyun, Takezako, Naoki, San-Miguel, Jesus, Moreau, Philippe,

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 65 KB

english, 2017

9

The DNA content of human plasma cells

Larry Brox, Dolores Mowles, Betty Pollock, Andrew Belch

Journal:

Year:

1981

Language:

english

File:

PDF, 310 KB

english, 1981

10

Expression of multiple β1 integrins on circulating monoclonal B cells in patients with multiple myeloma

Gitte S. Jensen, Andrew R. Belch, Michael J. Mant, Bernard A. Ruether, Bruce R. Yacyshyn, Dr. Linda M. Pilarski

Journal:

American Journal of Hematology

Year:

1993

Language:

english

File:

PDF, 715 KB

english, 1993

11

Multidrug transporter p-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: Modulation with differentiation stage and during aging

Linda M. Pilarski, Darlene Paine, Janet E. McElhaney, Carol E. Cass, Andrew R. Belch

Journal:

American Journal of Hematology

Year:

1995

Language:

english

File:

PDF, 1.13 MB

english, 1995

12

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma : A Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

Michael Crump, Tara Baetz, Stephen Couban, Andrew Belch, Deborah Marcellus, Kang Howson-Jan, Kevin Imrie, Robert Myers, Grenfell Adams, Keyue Ding, Nancy Paul, Lois Shepherd, Jose Iglesias, Ralph Meye

Journal:

Year:

2004

Language:

english

File:

PDF, 91 KB

english, 2004

13

Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma

Greg Dueck, Neil Chua, Angeli Prasad, Daygen Finch, Doug Stewart, Darrell White, Richard van der Jagt, James Johnston, Andrew Belch, Tony Reiman

Journal:

Year:

2010

Language:

english

File:

PDF, 144 KB

english, 2010

14

Promiscuity of translocation partners in multiple myeloma

Lorri D. Martin, Andrew R. Belch, Linda M. Pilarski

Journal:

Journal of Cellular Biochemistry

Year:

2010

Language:

english

File:

PDF, 206 KB

english, 2010

15

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study

Michael Hedenus, Magnus Adriansson, Jesus San Miguel, Mark H. H. Kramer, Martin R. Schipperus, Eeva Juvonen, Kerry Taylor, Andrew Belch, Albert Altés, Giovanni Martinelli, David Watson, James Matcham

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 218 KB

english, 2003

16

Treatment of multiple myeloma with deoxycoformycin

Andrew R. Belch, J. Frank Henderson, Larry W. Brox

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1985

Language:

english

File:

PDF, 506 KB

english, 1985

17

Association between exercise and quality of life in multiple myeloma cancer survivors

Lee W. Jones, Kerry S. Courneya, Jeffrey K. H. Vallance, Aliya B. Ladha, Michael J. Mant, Andrew R. Belch, Douglas A. Stewart, Tony Reiman

Journal:

Supportive Care in Cancer

Year:

2004

Language:

english

File:

PDF, 163 KB

english, 2004

18

Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study

Raul C. Urtasun, Martin Palmer, Brenda Kinney, Andrew Belch, Joanne Hewitt, John Hanson

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1998

Language:

english

File:

PDF, 769 KB

english, 1998

19

A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7

Chaim Shustik, Andrew Belch, Sue Robinson, Sheldon H. Rubin, Sean P. Dolan, Michael J. Kovacs, Kuljit S. Grewal, David Walde, Robert Barr, Jonathan Wilson, Kulwant Gill, Linda Vickars, Leona Rudinskas

Journal:

British Journal of Haematology

Year:

2007

Language:

english

File:

PDF, 760 KB

english, 2007

20

The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma

Robert P. Evans, Claudia Naber, Tara Steffler, Tamara Checkland, Christopher A. Maxwell, Jonathan J. Keats, Andrew R. Belch, Linda M. Pilarski, Raymond Lai, Tony Reiman

Journal:

British Journal of Haematology

Year:

2008

Language:

english

File:

PDF, 400 KB

english, 2008

21

High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program

Joseph R. Mikhael, Andrew R. Belch, H. Miles Prince, Maria Nambo Lucio, Angelo Maiolino, Alessandro Corso, Maria Teresa Petrucci, Pellegrino Musto, Mieczyslaw Komarnicki, A. Keith Stewart

Journal:

British Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 272 KB

english, 2009

22

Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry

Chow, Laura, Lai, Raymond, Dabbagh, Laith, Belch, Andrew, Young, James D, Cass, Carol E, Mackey, John R

Journal:

Modern Pathology

Year:

2005

Language:

english

File:

PDF, 246 KB

english, 2005

23

Immunohistochemical detection of cdc2 is useful in predicting survival in patients with mantle cell lymphoma

Hui, David, Reiman, Tony, Hanson, John, Linford, Rick, Wong, Winson, Belch, Andrew, Lai, Raymond

Journal:

Modern Pathology

Year:

2005

Language:

english

File:

PDF, 360 KB

english, 2005

24

Impaired Microvascular Function in Normal Children: Effects of Adiposity and Poor Glucose Handling

Faisel Khan, Fiona C. Green, J. Stewart Forsyth, Stephen A. Greene, Andrew D. Morris, Jill J. F. Belch

Journal:

The Journal of Physiology

Year:

2003

Language:

english

File:

PDF, 173 KB

english, 2003

25

In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival

Carina S. Debes Marun, Andrew R. Belch, Linda M. Pilarski

Journal:

American Journal of Hematology

Year:

2012

Language:

english

File:

PDF, 1.25 MB

english, 2012

26

Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients

Lorri D. Martin, Jana Harizanova, George Zhu, Christiaan H. Righolt, Andrew R. Belch, Sabine Mai, Linda M. Pilarski

Journal:

Genes, Chromosomes and Cancer

Year:

2012

Language:

english

File:

PDF, 1.76 MB

english, 2012

27

Similarities in long-term cultures of blood and bone marrow from patients with acute myelogenous leukemia

Hector Mayani, Gerald G. Miller, Anna Janowska-Wieczorek, A. Robert Turner, Andrew R. Belch, Donald W. Morrish, Suyun Shen, Jencet Tupas

Journal:

Year:

1991

Language:

english

File:

PDF, 637 KB

english, 1991

28

Inhibition by arabinosylcytosine of DNA synthesis in bone marrows of relapsed AML patients

Larry Brox, Dolores Mowles, Andrew Belch

Journal:

European Journal of Cancer (1965)

Year:

1965

Language:

english

File:

PDF, 474 KB

english, 1965

29

Sensitive detection using microfluidics technology of single cell PCR products from high and low abundance IgH VDJ templates in multiple myeloma

Linda M. Pilarski, Jana Lauzon, Erin Strachan, Sophia Adamia, Alexey Atrazhev, Andrew R. Belch, Christopher J. Backhouse

Journal:

Journal of Immunological Methods

Year:

2005

Language:

english

File:

PDF, 367 KB

english, 2005

30

Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma

Robert P. Evans, Greg Dueck, Roger Sidhu, Sunita Ghosh, Inka Toman, Jonathan Loree, Nizar Bahlis, Alexander C. Klimowicz, Joyce Fung, Michelle Jung, Raymond Lai, Linda M. Pilarski, Andrew R. Belch, To

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 1.13 MB

english, 2011

31

Expression of IL-6 and IL-6 receptors by circulating clonotypic B cells in multiple myeloma: Potential for autocrine and paracrine networks

Agnieszka J Szczepek, Andrew R Belch, Linda M Pilarski

Journal:

Experimental Hematology

Year:

2001

Language:

english

File:

PDF, 144 KB

english, 2001

32

Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice

Linda M Pilarski, Karen Seeberger, Robert W Coupland, Alana Eshpeter, Jonathan J Keats, Brian J Taylor, Andrew R Belch

Journal:

Experimental Hematology

Year:

2002

Language:

english

File:

PDF, 476 KB

english, 2002

33

Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia

Sophia Adamia, Mary Crainie, Jitra Kriangkum, Michael J. Mant, Andrew R. Belch, Linda M. Pilarski

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 94 KB

english, 2003

34

The malignant clone in Waldenstrom's macroglobulinemia

Jitra Kriangkum, Brian J. Taylor, Michael J. Mant, Steven P. Treon, Andrew R. Belch, Linda M. Pilarski

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 126 KB

english, 2003

35

Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study

George P. Browman, Andrew Belch, Jamey Skillings, Kenneth Wilson, Daniel Bergsagel, Dianne Johnston, Joseph L. Pater

Journal:

British Journal of Haematology

Year:

1992

Language:

english

File:

PDF, 447 KB

english, 1992

36

Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma

Edward A. Stadtmauer, Donna M. Weber, Ruben Niesvizky, Andrew Belch, Miles H. Prince, Jesús F. San Miguel, Thierry Facon, Marta Olesnyckyj, Zhinuan Yu, Jerome B. Zeldis, Robert D. Knight, Meletios A.

Journal:

European Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 168 KB

english, 2009

37

Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients

Maurizio Zangari, Monette Aujay, Fenghuang Zhan, Kristina L. Hetherington, Tamara Berno, Ravi Vij, Sundar Jagannath, David Siegel, A. Keith Stewart, Luhua Wang, Robert Z. Orlowski, Andrew Belch, Andrz

Journal:

European Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 100 KB

english, 2011

38

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)

Solh, Melhem, Rai, Kanti R., Peterson, Bercedis L., Kolitz, Jonathan E., Appelbaum, Frederick R., Tallman, Martin S., Belch, Andrew, Larson, Richard A., Morrison, Vicki A.

Journal:

Leukemia and Lymphoma

Year:

2013

Language:

english

File:

PDF, 571 KB

english, 2013

39

Hemolysis in mice treated with deoxycoformycin, am inhibitor of adenosine deaminase

Camila M. Smith, Andrew Belch, J.Frank Henderson

Journal:

Biochemical Pharmacology

Year:

1980

Language:

english

File:

PDF, 212 KB

english, 1980

40

Interleukin-6 (IL-6) and interferon gamma (IFNγ) expression in peripheral blood lymphocytes (PBMC) from multiple myeloma patients

Agnieszka J. Szczepek, Andrew R. Belch, Linda M. Pilarski

Journal:

Year:

1994

Language:

english

File:

PDF, 163 KB

english, 1994

41

Birth Weight Does Not Predict Blood Pressure in a Young Working Population: A Sharp (Scottish Heart and Arterial Disease Risk Prevention) Study

Gillian Libby, Shirley R. McEwan, Jill J. Belch, Andrew D. Morris

Journal:

Annals of Epidemiology

Year:

2008

Language:

english

File:

PDF, 95 KB

english, 2008

42

Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo

Daniel E. Lopes de Menezes, Linda M. Pilarski, Andrew R. Belch, Theresa M. Allen

Journal:

Biochimica et Biophysica Acta (BBA) - Biomembranes

Year:

2000

Language:

english

File:

PDF, 529 KB

english, 2000

43

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study

Michael Pfreundschuh, Anthony D Ho, Eva Cavallin-Stahl, Max Wolf, Ruth Pettengell, Ingrid Vasova, Andrew Belch, Jan Walewski, Pier-Luigi Zinzani, Walter Mingrone, Stein Kvaloy, Ofer Shpilberg, Ulrich

Journal:

The Lancet Oncology

Year:

2008

Language:

english

File:

PDF, 270 KB

english, 2008

44

An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib

Ravi Vij, David S. Siegel, Sundar Jagannath, Andrzej J. Jakubowiak, Alexander Keith Stewart, Kevin McDonagh, Nizar Bahlis, Andrew Belch, Lori A. Kunkel, Sandra Wear, Alvin F. Wong, Michael Wang

Journal:

British Journal of Haematology

Year:

2012

Language:

english

File:

PDF, 198 KB

english, 2012

45

In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival

Kyle J Thulien, Andrew R Belch, Tony Reiman, Linda M Pilarski

Journal:

Molecular Cancer

Year:

2012

Language:

english

File:

PDF, 409 KB

english, 2012

46

Origins of Waldenström's Macroglobulinemia: Does It Arise from an Unusual B-Cell Precursor?

Kriangkum, Jitra, Taylor, Brian J., Reiman, Tony, Belch, Andrew R., Pilarski, Linda M.

Journal:

Clinical Lymphoma

Year:

2005

Language:

english

File:

PDF, 171 KB

english, 2005

47

Potential Impact of a Single Nucleotide Polymorphism in the Hyaluronan Synthase 1 Gene in Waldenström's Macroglobulinemia

Adamia, Sophia, Treon, Steven P., Reiman, Tony, Tournilhac, Olivier, McQuarrie, Carrie, Mant, Michael J., Belch, Andrew R., Pilarski, Linda M.

Journal:

Clinical Lymphoma

Year:

2005

Language:

english

File:

PDF, 500 KB

english, 2005

48

Genetic Abnormalities in Waldenström's Macroglobulinemia

Adamia, Sophia, Pilarski, Patrick M., Belch, Andrew R., Pilarski, Linda M.

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 230 KB

english, 2009

49

Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

Weber, Donna M., Chen, Christine, Niesvizky, Ruben, Wang, Michael, Belch, Andrew, Stadtmauer, Edward A., Siegel, David, Borrello, Ivan, Rajkumar, S. Vincent, Chanan-Khan, Asher Alban, Lonial, Sagar, Y

Journal:

Boston Medical and Surgical Journal

Year:

2007

Language:

english

File:

PDF, 430 KB

english, 2007

50

Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma

Keats, Jonathan J., Reiman, Tony, Belch, Andrew R., Pilarski, Linda M.

Journal:

Leukemia and Lymphoma

Year:

2006

Language:

english

File:

PDF, 366 KB

english, 2006